Stockscreener 앱 받기
4.29
4.45%
-0.20
전일 마감가:
$4.49
열려 있는:
$4.5
하루 거래량:
750.87K
Relative Volume:
2.61
시가총액:
$8.08M
수익:
-
순이익/손실:
$-26.56M
주가수익비율:
-0.097
EPS:
-44.2199
순현금흐름:
$-28.59M
1주 성능:
-40.83%
1개월 성능:
-50.69%
6개월 성능:
+421.83%
1년 성능:
-25.71%
1일 변동 폭
$4.12
$4.525
1주일 범위
$4.12
$12.10
52주 변동 폭
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.29 | 8.46M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
Surprises Report: Is Simpple Ltd stock a value trapJuly 2025 PostEarnings & Free Community Supported Trade Ideas - baoquankhu1.vn
(BCT) Strategic Investment Report (BCT:CA) - Stock Traders Daily
ETF Watch: Does BriaCell Therapeutics Corp have a sustainable dividendMarket Risk Analysis & Verified Stock Trade Ideas - baoquankhu1.vn
The Globe’s stars and dogs for the week - The Globe and Mail
Philadelphia cancer therapy developer raises $30M amid signs of thaw in biotech funding - The Business Journals
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
BriaCell closes $30 million public offering to fund cancer immunotherapy By Investing.com - Investing.com Nigeria
BriaCell Therapeutics Completes $30 Million Public Offering - TipRanks
BriaCell closes $30 million public offering to fund cancer immunotherapy - Investing.com India
BriaCell Therapeutics Announces Closing of US$30 million Public Offering - Investing News Network
BriaCell Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
Why did BCTX stock surge 50% today? - MSN
BriaCell Therapeutics shares sink after $30 million capital raise - MSN
Market Review: Whats the profit margin of BriaCell Therapeutics Corp Equity Warrant2025 Pullback Review & Long-Term Growth Stock Strategies - baoquankhu1.vn
Quarterly Risk: What is the next catalyst for BriaCell Therapeutics CorpJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Market Trends: Does BriaCell Therapeutics Corp Equity Warrant stock have upside surprise potentialGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn
BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants - The Globe and Mail
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline - Intellectia AI
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush - The Globe and Mail
BriaCell Therapeutics Prices $30 Million Offering Amid 53.75% Stock Plunge - Intellectia AI
US-listed shares of BriaCell Therapeutics tumble 55% after company prices $30 mln public offering - marketscreener.com
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
BriaCell Therapeutics stock plummets after $30 million offering By Investing.com - Investing.com India
BriaCell Therapeutics stock plummets after $30 million offering - Investing.com
BriaCell Therapeutics Down 55% in Pre-Market, Announces US$30 Million Offering - marketscreener.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
What's Going On With BriaCell Therapeutics Stock Wednesday? - Benzinga
BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7% - GuruFocus
BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering - Nasdaq
BriaCell Therapeutics Brief: Announced Overnight Pricing Of US$30 Million Public Offering - marketscreener.com
BriaCell Therapeutics Prices $30 Million Public Offering of Stock, Warrants - marketscreener.com
BriaCell Therapeutics (BCTX) Launches $30M Public Offering - GuruFocus
BriaCell stock notches best day in 5 years on breast cancer data — then drops 10% after-hours: What went wrong? - MSN
BriaCell Stock Notches Best Day In 5 Years On Breast Cancer Data — Then Drops 10% After-Hours: What Went Wrong? - Asianet Newsable
BriaCell (BCTX) Reports Impressive Lung Metastasis Resolution in Cancer Trial - GuruFocus
BriaCell Prices Public Offering at $5.59 per Unit, Raising $30 Million - Intellectia AI
BriaCell prices $30 million public offering of units at $5.59 each - Investing.com India
Briacell Therapeutics announces pricing of $30 million public offering at $5.59 per unit - marketscreener.com
BriaCell Therapeutics Announces Pricing of $30 million Public Offering - marketscreener.com
ETF Watch: Can BriaCell Therapeutics Corp Equity Warrant stock sustain revenue growthJuly 2025 Review & High Accuracy Trade Alerts - Bộ Nội Vụ
BCTX Surges On Positive Clinical Response In Metastatic Cancer Immunotherapy Study - Nasdaq
Why Did BCTX Stock Surge 50% Today? - Asianet Newsable
BriaCell Reports Year-Long Complete Lung Metastasis Response in Breast Cancer Trial - TipRanks
Price Target Adjustments Send BCTX Stock Tumbling - timothysykes.com
BriaCell Surge Above 50%; What's The Buzz? - Nasdaq
BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS - TipRanks
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient - The Globe and Mail
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):